Massive insulin overdose

Detailed studies of free insulin levels and glucose requirements

Mary Samuels, Robert H. Eckel

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The course of a diabetic patient who self-administered 2500 U of NPH insulin subcutaneously was examined in detail. Despite resumption of oral intake on day 3, she required iv glucose for 6 days, during which time serum free insulin levels remained elevated. Glucose requirements closely matched those calculated from published euglycemic clamp data on maximal glucose disposal rates during insulin infusion. We postulate that her prolonged course was due to delayed absorption of the subcutaneous insulin. This is the first case of massive insulin overdose studied in such detail, and the results may facilitate management of future cases.

Original languageEnglish (US)
Pages (from-to)157-168
Number of pages12
JournalClinical Toxicology
Volume27
Issue number3
DOIs
StatePublished - 1989
Externally publishedYes

Fingerprint

Insulin
Glucose
Isophane Insulin
Glucose Clamp Technique
Clamping devices
Case Management
Serum
Subcutaneous Absorption

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Massive insulin overdose : Detailed studies of free insulin levels and glucose requirements. / Samuels, Mary; Eckel, Robert H.

In: Clinical Toxicology, Vol. 27, No. 3, 1989, p. 157-168.

Research output: Contribution to journalArticle

@article{304cd8ad9fdf43f785cab41bbfa81662,
title = "Massive insulin overdose: Detailed studies of free insulin levels and glucose requirements",
abstract = "The course of a diabetic patient who self-administered 2500 U of NPH insulin subcutaneously was examined in detail. Despite resumption of oral intake on day 3, she required iv glucose for 6 days, during which time serum free insulin levels remained elevated. Glucose requirements closely matched those calculated from published euglycemic clamp data on maximal glucose disposal rates during insulin infusion. We postulate that her prolonged course was due to delayed absorption of the subcutaneous insulin. This is the first case of massive insulin overdose studied in such detail, and the results may facilitate management of future cases.",
author = "Mary Samuels and Eckel, {Robert H.}",
year = "1989",
doi = "10.3109/15563658909038579",
language = "English (US)",
volume = "27",
pages = "157--168",
journal = "Clinical Toxicology",
issn = "1556-3650",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Massive insulin overdose

T2 - Detailed studies of free insulin levels and glucose requirements

AU - Samuels, Mary

AU - Eckel, Robert H.

PY - 1989

Y1 - 1989

N2 - The course of a diabetic patient who self-administered 2500 U of NPH insulin subcutaneously was examined in detail. Despite resumption of oral intake on day 3, she required iv glucose for 6 days, during which time serum free insulin levels remained elevated. Glucose requirements closely matched those calculated from published euglycemic clamp data on maximal glucose disposal rates during insulin infusion. We postulate that her prolonged course was due to delayed absorption of the subcutaneous insulin. This is the first case of massive insulin overdose studied in such detail, and the results may facilitate management of future cases.

AB - The course of a diabetic patient who self-administered 2500 U of NPH insulin subcutaneously was examined in detail. Despite resumption of oral intake on day 3, she required iv glucose for 6 days, during which time serum free insulin levels remained elevated. Glucose requirements closely matched those calculated from published euglycemic clamp data on maximal glucose disposal rates during insulin infusion. We postulate that her prolonged course was due to delayed absorption of the subcutaneous insulin. This is the first case of massive insulin overdose studied in such detail, and the results may facilitate management of future cases.

UR - http://www.scopus.com/inward/record.url?scp=0024459129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024459129&partnerID=8YFLogxK

U2 - 10.3109/15563658909038579

DO - 10.3109/15563658909038579

M3 - Article

VL - 27

SP - 157

EP - 168

JO - Clinical Toxicology

JF - Clinical Toxicology

SN - 1556-3650

IS - 3

ER -